Skip to content

CYTK

Cytokinetics, Incorporated

Stock

$65.62−0.29 (−0.44%)Close Oct 1, 2026

EBITDA (TTM)−$695M

EBITDA

PeriodEBITDAYoY
2025−$602M—
2024−$527M—
2023−$484M—
2022−$318M—
2021−$184M—
2020−$92M—
2019−$98M—
2018−$88M—
2017−$111M—
2016$19M—
2015−$37M—
2014−$14M—
2013−$33M—
2012−$40M—
2011−$47M—
2010−$48M—
2009$28M—